Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 5.76 M7.04 M6.3 M6.04 M6.28 M7.71 M 26.32 M Research & development —————— — Operating income 45.1 M48.54 M51.43 M54.95 M54.64 M52.4 M 213.42 M Non-Operating Income, Total 2.12 M1.26 M1.22 M2.33 M799 K3.77 M 8.13 M Interest expense, net of interest capitalized 29.46 M26.76 M25.32 M26.13 M25.73 M25.36 M 102.54 M Non-Operating Income, excl. Interest Expenses -27.35 M-25.5 M-24.1 M-23.8 M-24.93 M-21.59 M -94.42 M Unusual income/expense —————— — Pretax income 17.14 M22.76 M24.7 M27.68 M27.49 M27.5 M 107.38 M Equity in earnings 97 K13 K———— — Taxes 3.45 M4.71 M5.26 M5.81 M6 M5.69 M 22.76 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 13.68 M18.05 M19.45 M21.86 M21.49 M21.81 M 84.61 M Discontinued operations —————— — Net income 13.68 M18.05 M19.45 M21.86 M21.49 M21.81 M 84.61 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 13.68 M18.05 M19.45 M21.86 M21.49 M21.81 M 84.61 M Basic earnings per share (Basic EPS) 0.340.941.011.141.121.13 4.4 Diluted earnings per share (Diluted EPS) 0.350.931.011.131.111.12 4.37 Average basic shares outstanding 14.76 M19.16 M19.17 M19.22 M19.2 M19.27 M — Diluted shares outstanding 14.91 M19.33 M19.34 M19.36 M19.36 M19.41 M — EBITDA 13.9 M16.47 M23.74 M25.57 M32.89 M23.83 M 106.02 M EBIT 15.65 M21.78 M26.11 M28.81 M28.91 M27.04 M 110.88 M Cost of revenue 2.06 M-554 K209 K396 K75 K728 K 1.41 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) -1.23 M-4.57 M-2.38 M-3.24 M3.98 M-3.22 M -4.86 M